Modern prostate brachytherapy: Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up

Cancer

Volumn 89, Issue 1, 2000, Pages 135-141

  Ragde, Haakon ^a   Korb, Leroy J ^a   Elgamal, Abdel Aziz ^b   Grado, Gordon L ^c   Nadir, Brad S ^a  

^a Northwest Prostate Institute   (United States)

^b Northwest Biotherapeutics Inc   (United States)

^c Radiation Oncology/Brachytherapy   (United States)

Author keywords

Brachytherapy; Disease free survival; External beam radiation; Iodine 125; Prostate carcinoma; Prostate specific antigen; Radical prostatectomy; Results

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0034235709     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000701)89:1<135::aid-cncr18>3.0.co;2-%23     Document Type: Article

References (17)

1. Hudson R. Brachytherapy treatments increasing among Medicare population. Health policy brief. Baltimore, MD: American Urologic Association, Inc. 1999;IX:1.
2. Grado GL, Larson TR, Balch CS, Grado MM, Collins JM, Kriegshauser JS, et al. Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance. Int J Radiat Oncol Biol Phys 1998;42(2):289-98.
3. Blasko JC, Ragde H, Luse RW, Sylvester JE, Cavanagh W, Grimm PD. Should brachytherapy be considered a therapeutic option in localized prostate cancer? Urol Clin North Am 1996;23(4):633-50.
4. Ragde H, Elgamal AA, Snow PB, Brandt J, Bartolucci AA, Nadir BS, Korb LJ. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer 1998;83(5):989-1001.
5. Ragde H, Blasko JC, Grimm PD, Kenny GM, Sylvester JE, Hoak DC, et al. Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma [see comments]. Cancer 1997;80(3):442-53.
6. Ragde H, Blasko JC, Grimm PD, Kenny GM, Sylvester J, Hoak DC, et al. Brachytherapy for clinically localized prostate cancer: results at 7- and 8-year follow-up [published erratum appears in Semin Surg Oncol 1998;14(2):185]. Semin Surg Oncol 1997;13(6):438-43.
7. Wallner K. Iodine 125 brachytherapy for early stage prostate cancer: new techniques may achieve better results. Oncology (Huntington) 1991;5(10):115-22,5-6.
8. Stock RG, Stone NN, Tabert A, Iannuzzi C, DeWyngaert JK. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys 1998;41(1):101-8.
9. Bice WS Jr., Prestidge BR, Prete JJ, Dubois DF. Clinical impact of implementing the recommendations of AAPM Task Group 43 on permanent prostate brachytherapy using 1251. American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys 1998;40(5):1237-41.
10. Anonymous. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel [see comments]. Int J Radiat Oncol Biol Phys 1997;37(5):1035-41.
11. Holm HH, Juul N, Pedersen JF, Hansen H, Stroyer I. Transperineal iodine-125 seed implantation in prostate cancer guided by transrectal ultrasonography. J Urol 1983;130: 283-6.
12. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer [see comments]. JAMA 1998;280(11):969-74.
13. Stock RG, Stone NN, Wesson MF, DeWyngaert JK. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys 1995;32(1):219-25.
14. Stone NN, Stock RG. Brachytherapy for prostate cancer: real-time three-dimensional interactive seed implantation. Tech Urol 1995;1(2):72-80.
15. Critz FA, Levinson AK, Williams WH, Holladay CT, Griffin VD, Holladay DA. Simultaneous radiotherapy for prostate cancer: 125I prostate implant followed by external-beam radiation [see comments]. Cancer J Sci Am 1998;4(6):359-63.
16. Critz FA, Tarlton RS, Holladay DA. Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer. I-125 implant followed by external-beam radiation. Cancer 1995;75(9):2383-91.
17. Johansson JE, Adami HO, Andersson SO, Bergstrom R, Holmberg L, Krusemo UB. High 10-year survival rate in patients with early, untreated prostatic cancer [see comments]. JAMA 1992;267(16):2191-6.